baber/WOPTO huggingface dataset:
Patent MD-20010039-A (MD)
Title: Immunoreagent for microbial toxigenicity indication
Inventor: GHEORGHITA TUDOR
IPC: C12Q1/00
Filed: 2001-02-14
Abstract: The invention relates to microbiology and may be used for fast indication of microbial toxigenicity. Summary of the invention consists in that the immunoreagent includes antitoxin immune serum (antidiphtheritic or antistaphylococcic), fixed onto the carrier and 0,01% sodium merthiolate solution. In the capacity of carrier the immunoreagent contains particles of chlamydospores Ustilago maydis in the following ratio of ingredients, in mass %:antitoxin immune serum 20,0...50,0 particles of chlamidosporesUstilago maydis 8,0...12,0 sodium merthiolatesolution 0,01% the rest.The result of the invention consists in accelerating the indication, in increasing the reagent sensibility and specificity, as well as in prolonging the storage life.Claims: 1
Patent MX-157726-A (MX)
Inventor: PEZZOLI NELLO
IPC: D03D47/20
Filed: 1982-05-14
Abstract: In a drawing gripper for shuttleless looms, of the type comprising a fixed member (1) with a hook end (2) and a mobile oscillating element (3), the end of which cooperates with said hook in order to retain the weft yarn, said hook extends in a vertical plane and opens downwards. A vertical fin (6) is also provided on the fixed member to act as a yarn protection element.
Patent NZ-206555-A (NZ)
Title: Fibre optic cable: high voltage compatable
Inventor: CLABBURN R J T ATKINS A D LOOM
IPC: G02B6/44
Filed: 1983-12-12
Abstract: This invention relates to an arrangement comprising high voltage equipment, a fibre optic cable that is located in a region so as to be subject to the electric field of the equipment and to the flow of leakage current along the cable jacket, and electrically-conductive means mounted on the cable in said region so as to conduct to a point at earth potential leakage current flowing along the cable jacket. The said electrically-conductive means may comprise two inter-engaging half-shells. <IMAGE>
Patent NZ-209405-A (NZ)
Title: Heterocyclic oxamic acids and pharmaceutical compositions
Inventor: GROZINGER K G
IPC: C07D237/08
Filed: 1984-08-31
Abstract: Compounds of the formula <CHEM>  wherein  R1 is hydrogen or alkyl of 1 to 4 carbon atoms; R2 is hydrogen, methyl, hydroxyl, alkoxy of 1 to 4 carbon atoms, di(alkyl of 1 to 2 carbon atoms)amino-(alkoxy of 1 to 4 carbon atoms) or -HN-CO-CO-OR1;  A is <CHEM> R3 is hydrogen, methyl, alkoxy of 1 to 4 carbon atoms, hydroxyl, amino, alkanoyloxy of 1 to 2 carbon atoms, di(alkyl of 1 to 2 carbon atoms)amino-(alkoxy of 1 to 4 carbon atoms) or acetamido; and R4 is hydrogen, amino, alkoxy of 1 to 4 carbon atoms, halogen or -HN-CO-CO-OR1; and, when R1 is hydrogen, non-toxic, pharmacologically acceptable salts thereof. The compounds as well as their salts are useful for the treatment of immunological, inflammatory and allergic disorders such as allergic asthma, rhinitis, conjunctivitis, hay fever, urticaria, food allergies and the like.
Patent NZ-231612-A (NZ)
Title: N-substituted arylpiperidine derivatives and pharmaceutical compositions
Inventor: NAGEL ARTHUR ADAM
IPC: C07D211/14
Filed: 1989-12-01
Abstract: N-alkyl or oxyalkyl arylpiperidine cpds. of formula (I) are new. In (I), Ar = Ph, fluorophenyl, chlorophenyl, trifluoromethylphenyl, methoxyphenyl, tolyl or naphthyl opt. substd. with F, Cl, CF3 or OMe; n= 2-4; X= O, S or a direct bond; R= Ph, hydroxyphenyl, methoxyphenyl, tolyl, 2-amino-4-thiazolylphenyl, 5-oxindolyl, 2-methyl-4-oxo-4H-pyrido (1,2a)pyrimidin-3-yl, 7,9-dioxo-8-azaspiro(4,5)decan-8-yl or 1,8,8-trimethyl-2,4-dioxo -3-azabicyclo(3.2.1)heptan-3-yl. - Also new are arylpiperidine cpds. (II) from which (I) are prepd.. - (I) can be prepd. by reacting (II) with at least an equiv. amt. in moles of an aralkyl (or aryloxyalkyl) or heterocyclyl ether deriv. or corresp. halide of formula: Q(CH2)nXR where Q= a leaving gp. (e.g. p-toluenesulphonyloxy or halogen) in a reaction-inert polar organic solvent (partic. acetone or MIBK), under anhydrous conditions, in the presence of at least an equiv. amt of an appropriate base (partic. Na2CO3 or K2CO3). A temp. of 50-150 deg.C for 2-24 hrs. is used.
Patent NZ-240027-A (NZ)
Title: Detergent containing enzymes and a performance-enhancing amount of a polyhydroxy fatty acid amide
Inventor: MAO MARK HSIANG-KUEN
IPC: C11D1/66
Filed: 1991-09-30
Abstract: Disclosed is an improved detergent composition comprising one or more anionic surfactants, nonionic surfactants, or mixtures thereof, and detersive enzymes, the improvement which comprises incorporating into said composition an enzyme performance-enhancing amount of a polyhydroxy fatty acid amide material of formula (I), wherein R<1> is H1, C1-C4 hydrocarbyl, 2-hydroxy ethyl, 2-hydroxy propyl, or a mixture thereof, R2 is C5-C31 hydrocarbyl, and Z is a polyhydroxyhydrocarbyl having a linear hydrocarbyl chain with at least three hydroxyls directly connected to said chain, or an alkoxylated derivative thereof.
Patent NZ-243921-A (NZ)
Title: NUCLEOTIDE PROBE FOR THE 16S-rRNA GENE OF MYCOBACTERIA.
Inventor: YOUNG KAREN K Y
IPC: C12Q1/68
Filed: 1992-08-12
Abstract: Primers and probes can be used to detect nucleic acid from Mycobacterium in a sample and determine the species from which the nucleic acid originates. The primers amplify regions of the 16S ribosomal RNA gene and hybridize to regions conserved among species. Genus specific probes hybridize to sequences within the amplified region conserved among mycobacterial species, whereas the species specific probes hybridize to a variable region, so that the species identity can be uniquely determined. Consensus probes for detecting mycobacteria nucleic acids are provided which probes are not identical to any of the sequences of mycobacterial species.
Patent NZ-293258-A (NZ)
Title: 2-amino-1,2,3,4-tetrahydronaphthalene derivatives
Inventor: MONTANARI STEFANIA
IPC: A61P13/02
Filed: 1995-09-11
Abstract: Compounds of formula    <IMAGE>  (I)  wherein R, R', R'', R1, R2, R3, R4, R5, R6, X, Y, m, n and p have the meanings reported in the description; and their pharmaceutically acceptable salts are described. The compounds of formula I are useful in the treatment of arterial hypertension and congestive heart failure, of renal failure, of peripheral arteriopathies, of cerebrovascular insufficiencies and of ischemic cardiopathy.
Patent NZ-299098-A (NZ)
Title: Broadband distribution network incorporates a back-channel facility for two wire transmission of subscriber signals to centre
Inventor: HEIDEMANN ROLF
IPC: H04H20/76
Filed: 1996-07-31
Abstract: Each reverse channel equipment (4) is connected to a subscriber end amplifier (10) or a network connection point which is connected to a two wire line (21). The two wire line (21) is connected directly or indirectly to the exchange. The reverse channel equipment receives signals sent out from the subscriber end equipment . The reverse channel equipment then transmits the received signal to the exchange in accordance with a protocol which controls multiple access of the subscriber end equipment on the two wire line.
Patent NZ-332382-A (NZ)
Title: Vulcanized molding having surface decorative layer, painted thermoplastic resin composition, and painted elastomer composition
Inventor: KAWASAKI MASAAKI
IPC: C08F210/16
Filed: 1998-01-21
Abstract: A vulcanized molding having a surface decorative layer and possessing excellent mechanical strength and adhesion to the surface decorative layer, wherein the decorative layer is provided on the surface of either a vulcanization product of an unsaturated olefinic copolymer (A) prepared from ethylene (i), an aromatic vinyl compound (ii), a nonconjugated polyene (iii), and optionally an 'alpha'-olefin (iv) having 3 to 20 carbon atoms, or a vulcanization product of an olefinic elastomer (A) composition comprising the unsaturated olefinic copolymer and an ethylene/'alpha'-olefin copolymer rubber (E). The vulcanized molding can be used in automobile parts, building materials and other applications. A painted thermoplastic resin composition and a painted elastomer composition which have good adhesion to a paint film. The painted thermoplastic resin composition comprises a paint film provided on a molding of a thermoplastic resin composition comprising an ethylene/aromatic vinyl compound random copolymer and other thermoplastic resin. The painted elastomer composition comprises a paint film provided on a molding of an elastomer composition comprising an ethylene/aromatic vinyl compound random copolymer and an elastomer. These compositions can be widely used in applications where a paint film is provided, such as industrial materials and medical devices.
Patent NZ-334098-A (NZ)
Title: Apparatus and method for detecting surface defects
Inventor: GAUTHIER PIERRE
IPC: G01N21/898
Filed: 1997-08-08
Abstract: Apparatus and method for detecting surface defects on an article 104 freely standing on a conveyer 100, which generate profile trace data corresponding to profile trace at a cross section of the article, is disclosed.  A surface shape inspection unit comprising an optical ranging system using laser 108 and camera 128 is provided for obtaining the profile trace data through triangulation-based derivation techniques.  Base reference curves are derived from regular portions of the profile trace data.  Profile trace data are compared to defect threshold curves to recognize a defect induced departure of the trace data with respect to the base reference curve and to produce a defect output signal.  The apparatus and method are particularly useful for detecting roughness, cavities, wane, missing wood and altered wood on lumber pieces which are conveyed at high speed.
Patent NZ-335342-A (NZ)
Title: Method for identifying mutations by selectively breeding mice to produce a desired phenotype with the mutation
Inventor: DOVE WILLIAM F
IPC: C12Q1/68
Filed: 1997-11-18
Abstract: A method for identifying a segregating mutation at a murine genetic locus wherein the segregating mutation causing an outlying phenotype relative to the index phenotype in an index inbred non-human strain such as a mouse strain comprises: a)	outcrossing a non-human founder isogenic inbred strain with a non-human index inbred strain to obtain Gen1F1 progeny; the founder isogenic inbred strain is heterozygous only for random point mutations relative to a wild-type animal of the founder inbred strain; the index inbred strain carries a dominant allele at a locus known to confer the index phenotype; wherein at least some of the Gen1F1 progeny carry both the dominant allele and at least one random mutation; b)	crossing a founder animal of the founder isogenic inbred strain to an animal of the founder strain that lacks the mutations to obtain inbred Gen2 offspring; wherein the founder animal has at least one outcrossed F1 progeny that displays the outlying phenotype relative to the index phenotype; c)	outcrossing Gen2 offspring to the index strain to obtain Gen2F1 backcross progeny, half of which, on average, carry the dominant allele that confers the index phenotype and d)	verifying that a subset of the Gen2F1 progeny shows the outlying phenotype.
Patent NZ-502767-A (NZ)
Title: Anti-first-pass effect compounds
Inventor: HARRIS JAMES W
IPC: C07D493/10
Filed: 1998-08-26
Abstract: Compounds of formula I-IV wherein: R is independently H or an optionally substituted C1-C15 alkyl group; L is an optionally substituted C1-C15 linear or branched, saturated, monounsaturated, or polyunsaturated alkyl group optionally terminated at one or both ends by oxygen; HAr is an optionally substituted C6-C24 aromatic group or heteroaromatic group optionally containing one or plural ring atoms selected from N, O, S, or P; and E is -OH, -COOH, -COOR (R is as defined above) or an optionally substituted C1-C8 linear or branched, saturated, monounsaturated or polyunsaturated alkyl group optionally interrupted by one or more nonadjacent O or S atoms, or E is a C3-C8 optionally substituted cyclic saturated, monounsaturated or polyunsaturated alkyl group optionally interrupted by one or more nonadjacent O or S atoms or E is optionally substituted HAr. The optional substituents for R, L, HAr and E are selected from a C1-C6 linear, branched, or cyclic alkyl group, -OH, halogen, a C1-C5 alkoxy group, a C1-C5 carbonyloxy group or a C1-C5 alkoxycarbonyl group. The compounds are used for co-administration with a drug in order to inhibit the first pass effect of the drug.
Patent NZ-504933-A (NZ)
Title: Substituted quinoline-carboxylic acid (pyridinyl)amides and use as inhibitors of tumour necrosis factor and phosphodiesterase-IV
Inventor: MONTANA JOHN GARY
IPC: C07D401/12
Filed: 1999-11-02
Abstract: In formula (i), R1 is CH3, CH2F, CHF2 or CF3; R2 is CH3 or CF3; R3 is F, Cl, Br, CN or CH3; and R4 is H, F, Cl, Br, CN or CH3. The compounds of formula (i) are inhibitors of phosphodiesterase IV or Tumour Necrosis Factor and may be used in medicaments for the treatment of inflammatory disease, autoimmune disease, asthma, chronic bronchitis, chronic pulmonary inflammatory disease, chronic obstructive airways disease, atopic dermatitis, allergic rhinitis, psoriasis, arthritis, rheumatoid arthritis, joint inflammation, ulcerative colitis, Crohn's disease, atopic eczema, stroke, bone resorption disease, multiple sclerosis, inflammatory bowel disease, urticaria, allergic conjunctivitis, vernal conjunctivitis, inflammation of the eye, allergic responses in the eye, eosinophilic granuloma, gouty arthritis and other arthritic conditions, adult respiratory distress syndrome, diabetes insipidus, keratosis, cerebral senility, multi-infarct dementia, senile dementia, memory impairment associated with Parkinson's disease, depression, cardiac arrest, intermittent claudication, rheumatoid spondylitis, osteoarthritis, sepsis, septic shock, endotoxic shock, gram negative sepsis, toxic shock syndrome, acute respiratory distress syndrome, cerebral malaria, silicosis, pulmonary sarcoidosis, reperfusion injury, graft vs host reaction, allograft rejection, infection-related fever or myalgia, malaria, HIV, AIDS, ARC, cachexia, keloid formation, scar tissue formation, pyresis, systemic lupus erythematosus, type I diabetes mellitus, Bechet's disease, anaphylactoid purpura nephritis, chronic glomerulonephritis, leukaemia, tarditive dyskinesia, yeast or fungal infection, conditions requiring gastroprotection, and neurogenic inflammatory disease associated with irritation and pain.
Patent NZ-505027-A (NZ)
Title: Novel process for preparing a ketimine
Inventor: COLBERG JUAN CARLOS
IPC: C07C251/20
Filed: 1998-10-15
Abstract: A simplified process for the preparation of N-[4-(3,4- dichlorophenyl) -3,4-dihydro-1(2H)- naphthalenylidene]methanamine (Formula II, a critical intermediate in the production of sertraline) from 4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone (Formula I) and monomethylamine using an alcohol as the dehydrating agent.  The alcohol used is an alcohol that has a boiling point greater than 55oC under reaction conditions, and in which monomethylamine is soluble.
Patent NZ-505085-A (NZ)
Title: Pharmaceutical compositions comprising bipapcitide monocarboxylate and/or bipapcitide dicarboxylate for imaging and treating thrombi
Inventor: DEAN RICHARD T
IPC: A61K38/16
Filed: 1999-02-05
Abstract: Reagents comprising bibapcitide monocarboxylate, bibapcitide dicarboxylate and compositions thereof including bibapcitide. Also described are pharmaceutical compositions of the above compounds.
Patent NZ-511017-A (NZ)
Title: Dispensing closure assembly for adhesive with cover having frangible outer portion and inner portion that seals over cap
Inventor: PAGLIARO JOSEPH B
IPC: B65D47/10
Filed: 1999-09-15
Abstract: A dispensing closure assembly positionable over an open end of a container includes a cap (12) attachable to the end of the container and having a sealable opening in fluid communication with the contents within the container.
Patent NZ-511385-A (NZ)
Title: Sonified vortex machine for communition and treatment of solids
Inventor: YOUDS MARK WILLIAM
IPC: C02F1/72
Filed: 2001-05-01
Abstract: A vortexian machine for processing material includes a material feed inlet tube H widening via a conical portion J to a rotor with between 8 and 12 radial vanes housed in a rotor enclosure and driven by an engine.  Material is centrifugally ejected by the rotor to enter into a cyclone from which the processed material is collected.  The machine includes an "interrupter" spinning at the rotor hub.  By appropriate choice of the dimensions of the parts of the machine and the rotational speeds of the rotor, energetic matter processing is said to occur in the vicinity of the rotor hub.
Patent NZ-513029-A (NZ)
Title: Method for making a non-contact smart card with an antenna support made of fibrous material
Inventor: KAYANAKIS GEORGES
IPC: G06K19/077
Filed: 2000-11-28
Abstract: A manufacturing process of a contactless smart card with an antenna support (28) made of fibrous material such as paper comprises: a manufacturing process of the antenna (38) consisting in screen printing turns (36) of electrically conductive polymer ink on a support made of fibrous material and to subject the support to a heat treatment in order to bake the ink; a bonding step using electrically conductive adhesive (42) to bond the chip's (40) bonding pads onto the antenna's (38) bonding pads and a lamination of a card body on each side of the support wherein the card body comprises at least two sheets (30, 32, 34) of plastic material having different stiffness by a hot press moulding process.
Patent NZ-513625-A (NZ)
Title: Incinerator with ceramic filter
Inventor: MAEJIMA TAKASHI
IPC: F23G5/44
Filed: 2000-09-01
Abstract: The device relates to an incinerator with a ceramics filter for incinerating raw refuse, general garbage, expanded polystyrene and others generated from a manufacturing plant, a wholesale market, a general firm, a general retail store, a general house and others. According to the provisions of the device, air intakes having a check valve provided thereto are formed to right and left lower portions of an incinerator; an oast is set in a combustion chamber; a tabular ceramics filter for removing a harmful substance is attached to the upper portion of the oast; and a suction port is formed to the upper portion of the tabular ceramics filter.
Patent NZ-514691-A (NZ)
Title: Method to type prion proteins
Inventor: COLLINGE JOHN
IPC: A61P25/28
Filed: 2000-04-07
Abstract: The invention relates to methods and materials for use in the typing, diagnosis, prevention and/or treatment of prion disease.
Patent NZ-516823-A (NZ)
Title: Zeolite SSZ-52
Inventor: LEE GREGORY S
IPC: C07D295/037
Filed: 2000-06-20
Abstract: The present invention relates to new crystalline zeolite SSZ-52 prepared using a quaternary ammonium cation templating agent having the structurewhere X- is an anion which is not detrimental to the formation of the SSZ-52. SSZ-52 is useful in catalysts for hydrocarbon conversion reactions.
Patent NZ-519697-A (NZ)
Title: Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds
Inventor: LIPSON KEN
IPC: A61K31/405
Filed: 2000-12-22
Abstract: Use of an indolinone compound selected from the formulae in the preparation of a medicament for treating or preventing one or more gastrointestinal stromal tumors, allergy associated chronic rhinitis, inflammation or asthma in an organism; and the use of an indolinone compound of formula (II) in the preparation of a medicament for treating or preventing mastocytosis, allergy associated chronic rhinitis, inflammation, asthma, or one or more mast cell tumors in an organism
Patent NZ-522387-A (NZ)
Title: Methods for inhibiting proliferation and inducing apoptosis in cancer cells
Inventor: ADRIAN THOMAS E
IPC: A61K31/41
Filed: 2001-05-08
Abstract: The use of a compound effective to inhibit binding  of leukotriene   B4   to  leukotriene  B4   receptor   in   the manufacture of a medicament for decreasing proliferation  of adenocarcinoma  cancer  cells, or of inducing  apoptosis  of adenocarcinoma  cancer cells, or of inducing differentiation of  adenocarcinoma  cancer cells into  non-cancerous  cells. Also disclosed are compounds of formula (I) for used in  the above  medicaments,  wherein the  substituents  are  defined herein.
Patent NZ-524243-A (NZ)
Title: Harvesting device with disengagable shaker members for a fruit harvesting machine
Inventor: CAMILLE JEAN MERANT
IPC: A01D46/28
Filed: 2001-09-04
Abstract: A harvesting device, in particular for fruit harvesting machines, includes a straddling chassis, two shaker assemblies (5) mounted face-to-face on the chassis to shake the fruit trees or bushes and detach the fruits, berries or the like from them, each shaker assembly including drive means (19, 21, 24) including a vertical shaft (24) oscillating about a vertical axis (20), a plurality of flexible rods (22), vertically spaced and extending horizontally, each rod having a first end (22a) detachably coupled to the drive means, a median part (22c) and a second end (22b) connected to the chassis (9); the first end (22a) of each rod (22) is mounted on the vertical shaft (24) so that it can rotate relative to said vertical shaft and is coupled to the drive means so that, in the coupled state, the corresponding rod assumes a working position in which the median part of the rod is relatively close to said median vertical plane of symmetry and is able to operate on the fruit trees of symmetry and is able to operate on the fruit trees or bushes whereas, in the uncoupled state, said rod is able, because of said rotation relative to said vertical shaft, to assume an inactive rest position in which the median part of the rod is substantially farther away from the vertical median plane of symmetry than in the working position and is unable to operate on the fruits trees or bushes.
Patent NZ-524543-A (NZ)
Title: Remote control system for a locomotive using voice commands
Inventor: HORST FOLKERT
IPC: B61L17/00
Filed: 2001-07-11
Abstract: A remote control system for a locomotive includes a lead controller (12) and follower controller (14) connected to one another over a wireless communication link (16). The lead controller (12) issues commands over the wireless communication link (16) and those commands are implemented by the follower controller (14) mounted on-board the locomotive. The lead controller (12) is responsive to voice commands uttered by the operator and can detect whether use is authorised to use it.
Patent NZ-526690-A (NZ)
Title: Mikanolide derivatives, their preparation and therapeutic uses
Inventor: LAVERGNE OLIVIER
IPC: A61P13/08
Filed: 2002-01-11
Abstract: Mikanolide derivatives, their preparation and their therapeutic uses are disclosed. The compounds correspond to general formula (I) corresponding to general sub-formulae (I)1 and (I)2, wherein: R1 represents H, SR4 or NR4R5; R2 represents SR6 or NR6R7; R3 represents OH, O(CO)R14, OSiR15R16R17, O(CO)OR18 or O(CO)NHR18, each of the radicals R4, R6, R15, R16 and R17 representing independently (in particular) an alkyl radical, the radicals R5 and R7 representing (in particular) radicals selected independently from a hydrogen atom and an alkyl radical, and each of the radicals R14 and R18 representing independently (in particular) an alkyl or cycloalkyl radical, or one of aryl, heteroaryl, aralkyl or heteroalkyl radicals optionally substituted; provided that when the compounds correspond to the general sub-formula (I)2, then R1 does not represent a hydrogen atom. The compounds disclosed are used in the manufacture of a medicament intended to inhibit DNA polymerases, to treat diseases due to abnormal cell proliferation, to treat cancer, to treat atherosclerosis, benign hyperplasia of the prostate and fibroses, to treat viral diseases, to treat parasitic diseases or to treat diseases of bacterial origin.